Unknown

Dataset Information

A retrospective cohort study of low-dose intensity-modulated radiotherapy for unresectable liver metastases.


ABSTRACT:

Objective

To evaluate the efficacy and toxicity of intensity-modulated radiotherapy (IMRT) for the treatment of unresectable liver metastases.

Methods

Twenty-five patients with unresectable liver metastases treated with IMRT were enrolled from January 2003 to September 2016. The median longest diameter of the lesions was 3.3 cm (range, 1.6-16.7 cm). The fraction dose ranged from 2 to 5.2 Gy, with a median total dose of 50 Gy (range, 30-60 Gy).

Results

The median follow-up was 9.2 months (range, 2.1-48.8 months). The overall survival rates at 1 and 2 years were 46.4% and 27.4%, respectively. The 1-year local control rate was 69.8%. The 1-year progression-free survival rate was 26.3%. One patient had grade 4 liver dysfunction. One case of grade 4 leukopenia and one case

SUBMITTER: Pei S 

PROVIDER: S-EPMC7607147 | biostudies-literature | 2020 Apr

REPOSITORIES: biostudies-literature